176 related articles for article (PubMed ID: 7276986)
21. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
[TBL] [Abstract][Full Text] [Related]
22. Carrier testing in families of isolated cases of duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity.
Nicholson GA; Lane RJ; Gardner-Medwin D; Walton JN
J Neurol Sci; 1981 Jul; 51(1):29-42. PubMed ID: 7252519
[TBL] [Abstract][Full Text] [Related]
23. The significance of simultaneous estimation of serum creatine kinase and myoglobin in neuromuscular diseases.
Diószeghy P; Mechler F
J Neurol; 1988 Jan; 235(3):174-6. PubMed ID: 3367167
[TBL] [Abstract][Full Text] [Related]
24. Duchenne muscular dystrophy: does serum myoglobin correlate with serum creatine kinase?
Kiessling WR; Beckmann R
Muscle Nerve; 1981; 4(3):257. PubMed ID: 7242564
[No Abstract] [Full Text] [Related]
25. Hereditary progressive muscular dystrophies: serum myoglobin pattern in patients with different types of muscular dystrophies.
Pöche H; Kattner E; Beckmann R; Pernice W; Schneider V
Clin Physiol Biochem; 1989; 7(1):40-6. PubMed ID: 2752671
[TBL] [Abstract][Full Text] [Related]
26. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
[TBL] [Abstract][Full Text] [Related]
27. Myoglobinemia in children with progressive muscular dystrophy.
Ando T; Shimizu T; Kato T; Ohsawa M; Fukuyama Y
Clin Chim Acta; 1978 Apr; 85(1):17-22. PubMed ID: 647964
[TBL] [Abstract][Full Text] [Related]
28. Creatine kinase activity in the detection of carriers of Duchenne muscular dystrophy: comparison of two methods.
Tippett PA; Dennis NR; Machin D; Price CP; Clayton BE
Clin Chim Acta; 1982 Jun; 121(3):345-59. PubMed ID: 7105400
[TBL] [Abstract][Full Text] [Related]
29. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
[TBL] [Abstract][Full Text] [Related]
30. The significance of the estimation of serum myoglobin in neuromuscular diseases.
Hische EA; van der Helm HJ
J Neurol Sci; 1979 Oct; 43(2):243-51. PubMed ID: 512682
[TBL] [Abstract][Full Text] [Related]
31. Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT).
Herrmann FH; Spiegler AW
J Neurol Sci; 1983 Dec; 62(1-3):141-6. PubMed ID: 6668470
[TBL] [Abstract][Full Text] [Related]
32. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
Lange K; Zatz M
Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
[TBL] [Abstract][Full Text] [Related]
33. Potential of radioimmunoassay of myoglobin in amniotic fluid and serum in prenatal diagnosis of Duchenne muscular dystrophy.
Hansen KN; Lademann A; Nørgaard-Pedersen B
Lancet; 1978 Dec; 2(8102):1250-1. PubMed ID: 82750
[No Abstract] [Full Text] [Related]
34. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
Hughes RC; Park DC; Parsons ME; O'Brien MD
J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
[TBL] [Abstract][Full Text] [Related]
35. Carrier detection in Becker muscular dystrophy using creatine kinase estimation and DNA analysis.
Kingston HM; Sarfarazi M; Newcombe RG; Willis N; Harper PS
Clin Genet; 1985 Apr; 27(4):383-91. PubMed ID: 3995787
[TBL] [Abstract][Full Text] [Related]
36. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
[TBL] [Abstract][Full Text] [Related]
37. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women.
Smith I; Elton RA; Thomson WH
Clin Chim Acta; 1979 Nov; 98(3):207-16. PubMed ID: 498534
[No Abstract] [Full Text] [Related]
38. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
[TBL] [Abstract][Full Text] [Related]
39. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
Sibert JR; Harper PS; Thompson RJ; Newcombe RG
Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
[TBL] [Abstract][Full Text] [Related]
40. Detection and identification of myoglobin in serum by immunoblotting. Effect of exercise on patients with Duchenne muscular dystrophy.
Pöche H; Hopfenmüller W; Hoffmann M
Clin Physiol Biochem; 1987; 5(2):103-11. PubMed ID: 3304774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
